Who is sponsoring NCT04100395?

NCT04100395 is sponsored by Assiut University.

What drugs are being tested in NCT04100395?

Interventions in NCT04100395: sonoclot.

What condition does NCT04100395 study?

NCT04100395 studies Study of Hemostatic Profile in Traumatic Patients.

Is NCT04100395 still recruiting?

NCT04100395 is currently not yet recruiting. Last updated 24 September 2019.

Last reviewed 2019-09-24 · How we verify

NCT04100395

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Global Hemostasis Monitoring by Using Sonoclot Signature in Traumatic Patients

Not yet recruiting Last updated 24 September 2019

What this trial tests

trial testing sonoclot in Study of Hemostatic Profile in Traumatic Patients in 40 participants. Not yet recruiting.

Timeline

15 September 2019

Primary endpoint
15 October 2022

15 October 2032

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	40
Start date	15 September 2019
Primary completion	15 October 2022
Estimated completion	15 October 2032

Drugs / interventions tested

sonoclot

Conditions studied

Study of Hemostatic Profile in Traumatic Patients — all drugs for Study of Hemostatic Profile in Traumatic Patients →

Sponsor

Assiut University

Who can join

Adults 18 to 70, any sex, with Study of Hemostatic Profile in Traumatic Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Analyzing the effects of severe trauma using sonoclot analyzer (which depicts the entire hemostatic pathway) ,subsequently describing the convenient therapy . 2. Assessing the correlations between sonoclot variables and conventional coagulation and platelet function tests

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04100395 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 24 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04100395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing